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Experimental inoculation of naive ducks with duck hepatitis B virus (DHBV) can lead to one of three outcomes, namely,
persistent viremia, transient infection with or without viremia, or no evidence of infection. The ability of individual ducks to
resolve DHBV infection was found to be linked to the age of the duck at the time of inoculation and the dose of inoculated
virus. (1) In recently hatched ducks inoculated intravenously (i.v.) with 4 3 104 DHBV DNA genomes, a switch from persistent
viremia to transient antibody appearance was seen at an age of inoculation between 7 and 14 days. A 25-fold increase in the
dose of virus (1 3 106 DHBV genomes) delayed this switch by 7 days. (2) When 4-month-old ducks were inoculated i.v. with
different doses of virus, only those receiving the highest dose (2 3 1011 DHBV genomes) showed viremia and extensive viral
replication and histological changes in the liver; 2/3 ducks in this group had a transient infection, while the third duck had
viral replication and histological changes in the liver that were still present at day 120 postinoculation (p.i.). In all ducks
receiving lower doses (1 3 103, 1 3 106, 1 3 109 DHBV genomes) antibodies to viral surface and core antigens developed
without detectable viral replication in the liver on days 6, 9, or 12 p.i. (3) When 10- to 16-month-old ducks were inoculated i.v.
with 2 3 1011 DHBV genomes, all showed extensive viral replication in hepatocytes and mild to moderate histological
changes in the liver on days 4 or 6 p.i. In 4/5 ducks viremia was not detected, anti-surface antibodies were first detected on
day 8 p.i., and viral DNA and antigen were cleared from the liver by days 35–47 p.i. The remaining duck became viremic with
persistence of virus in the liver until at least day 46 p.i. The findings of the study are consistent with a model for noncytopathic
viruses (R. M. Zinkernagel (1996) Science 271, 173–178). © 1998 Academic Press
INTRODUCTION
Hepadnaviruses can cause either transient or persis-
tent infection of their hosts. The outcome of both hepa-
titis B virus (HBV) and duck hepatitis B virus (DHBV)
infection is strongly age-dependent. In humans, HBV
infection of neonates usually leads to persistent infec-
tion, while HBV infection of adults results in persistent
infection in 5–10% of individuals and transient infection
with immunity to reinfection in the remainder. Similarly,
studies with the woodchuck hepatitis virus (WHV) and
the DHBV experimental models have demonstrated per-
sistent infection following transmission of virus to neo-
natal animals (Cullen et al., 1989; Gerin, 1990; Jilbert et
al., 1988, 1996; Marion et al., 1984, 1987; Tagawa et al.,
1985), while infection of older animals is usually transient
(Fukuda et al., 1987; Jilbert et al., 1992; Kajino et al., 1994;
Qiao et al., 1990; Vickery and Cossart, 1996). However,
there is no clear evidence whether persistence of infec-
tion in neonates results from enhanced capacity for im-
mature cells to produce viral progeny, a lower capacity
for immune responsiveness in the young, an interplay of
both, or some other mechanism(s). A recent model for
the outcome of infection with noncytopathic viruses
(Zinkernagel, 1996) proposed that variability in outcome
(e.g., transient or persistent infection) may depend on the
balance between viral parameters and variables of the
immune system. Viral parameters may include dose of
inoculum, kinetics of viral replication and dissemination,
and cell and tissue tropism, which are balanced against
the specificity, kinetics, and duration of humoral and
cell-mediated immunity.
HBV is a noncytopathic virus that replicates primarily
in hepatocytes. Immune responses to HBV infection are
likely to be responsible for the liver damage seen in both
transient and persistent infection and for the clearance
of virus from infected cells (Chisari and Ferrari, 1995). It
has been widely assumed that viral clearance is medi-
ated chiefly by destruction of infected cells by cytotoxic T
lymphocytes. However, in vivo studies of transient DHBV
and WHV infections (Jilbert et al., 1992; Kajino et al., 1994)
have suggested that clearance of hepadnavirus infection
from the liver may occur by noncytolytic mechanisms. In
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these studies .95% of hepatocytes were shown to sup-
port viral replication at the peak of infection. Infections
were rapidly cleared from the liver, coincident with de-
tectable anti-surface antibodies in serum. Although viral
replication was accompanied by mild to moderate mono-
nuclear cell infiltration of the liver and increases in levels
of liver enzymes in the serum, histological evidence of
significant cell regeneration was not observed. Further
evidence for noncytolytic clearance of hepadnavirus in-
fection comes from studies of HBV transgenic mice
(Guidotti et al., 1996). In these studies cytotoxic lympho-
cytes were involved in damage of a relatively small
number of hepatocytes, while TNF-a and IFN-g produc-
tion by these or other cells that they activate resulted in
down-regulation of HBV gene expression without neces-
sarily causing cell death. However, details of the mech-
anisms of resolution of hepadnavirus infection remain to
be clarified. In addition, the basis for impairment of the
ability of neonates and some adults to clear viral infec-
tion has not been adequately addressed.
The effect of dose was one of the parameters exam-
ined in a previous study of 26-day-old ducks (Vickery and
Cossart, 1996) where intravenous inoculation of 4.8 3
108 DHBV genomes resulted in persistent viremia, while
lower doses produced transient infection with or without
viremia. Fukuda et al. (1987) examined the effect of age
on the outcome of DHBV infection and found that 1- and
3-day-old ducks inoculated with a constant dose of
DHBV (;1 3 108 DHBV genomes via the leg vein) de-
veloped persistent viremia, whereas ducks inoculated at
5 days of age and older showed persistent or transient
viremia. Another study in 1- to 56-day-old ducks used
variable high doses of virus that were increased in par-
allel with the age and weight of the duck (Qiao et al.,
1990). Inoculation of ducks up to 21 days of age resulted
in persistent viremia, while viremia was detected in only
80 and 60% of ducks inoculated at 28 and 42 days of age,
respectively; 70% of the viremic ducks became carriers.
The current study was designed to define the outcome
of infection and serological responses in ducks of differ-
ent ages (1–42 days old) receiving a constant low dose of
DHBV and to characterize in more detail the serological
responses and course of infection in older ducks after
inoculation of varying doses of virus. The long-term aims
were to define more clearly the conditions leading to the
different outcomes of infection, the mechanism of reso-
lution of transient infection, and the factors that govern
whether an infection is transient or persists.
RESULTS
The effect of age and dose of inoculated virus on the
outcome of infection in 1- to 42-day-old ducks
Infection with both DHBV and HBV at a younger age
favors the persistence of viral infection. To examine this
effect in detail groups of ducks were inoculated at 1–42
days of age with a constant low dose of DHBV (4 3 104
genomes). Four of four 1-day-old ducks and three of four
7-day-old ducks developed detectable viremia (DHBV
DNA and DHBsAg) and anti-DHBc antibodies that per-
sisted until the end of the study at day 56 p.i. Liver
tissues collected on day 56 p.i. from ducks with persis-
tent viremia had DHBsAg staining in .95% of hepato-
cytes. In contrast, in the remaining 7-day-old duck and all
older ducks, no viremia was detected, and anti-DHBc
and/or anti-DHBs antibodies developed in most ducks
(Table 1). Liver tissues collected from these ducks on day
56 p.i. were negative for DHBsAg and DHBV DNA. Thus,
in all ducks, viremia persisted if it developed to detect-
TABLE 1
Serological Outcomes of Infection Following Inoculation of Groups of Newly Hatched Ducks
at Different Ages with either 4 3 104 or 1 3 106 DHBV Genomes
Age at
inoculation
(days)
DHBsAg/DHBV DNAa Anti-DHBsb Anti-DHBcb
4 3 104 c 1 3 106 c NDSc 4 3 104 1 3 106 NDSc 4 3 104 1 3 106 NDSc
1 4/4d ND 0/1 0/4 ND 0/1 3/4 ND 0/1
7 3/4 1/2 0/1 2/4 0/2 0/1 3/4 0/2 0/1
14 0/4 2/2 0/1 2/4 0/2 0/1 2/4 1/2 0/1
21 0/2 0/2 0/1 2/2 2/2 0/1 1/2 2/2 0/1
28 0/2 0/1 0/1 1/2 1/1 0/1 1/2 0/1 0/1
35 0/2 0/1 0/2 0/1 0/1 0/1
42 0/2 0/1 1/2 0/1 0/2 0/1
a DHBV DNA was detected in 5-ml serum samples by spot blot hybridization and DHBsAg was detected by ELISA as described in the text. The
presence of DHBV DNA coincided in every sample with the presence of DHBsAg. Since transient viremia was not detected in any of the ducks in
this experiment, detection of DHBsAg and DHBV DNA as shown above indicates persistent viremia.
b Anti-DHBs and anti-DHBc antibodies were detected in serum samples by ELISA as described in the text. In some cases transient antibody
responses were detected and these are listed above as a positive response.
c Ducks were inoculated i.v. with dilutions of pooled serum containing 4 3 104 or 1 3 106 DHBV genomes or with NDS alone.
d The presence of each marker is expressed as number of ducks positive/total number of ducks in the group.
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able levels and in newly hatched ducks was a indicator
of viral infection that persisted until at least day 56 p.i.
An example of the typical serological profile of a duck
that developed persistent viremia following inoculation
at 1 day of age (duck 1.2) is shown in Fig. 1A. DHBsAg
and DHBV DNA were detected from day 10 p.i. until the
end of the study and anti-DHBc antibodies were de-
tected from day 17 p.i. onward (Fig. 1A; Table 1). Thus
ducks inoculated at 1 day of age were able to mount
humoral immune responses to infection (anti-DHBc an-
tibodies) that were not sufficient to resolve infection.
Anti-DHBs antibodies were detected in serum samples
collected from day 29 p.i. onward in duck 1.2 at levels just
above the cutoff value. The detection of anti-DHBs anti-
bodies in the presence of DHBsAg is analogous to the
similar finding of anti-HBs antibodies in some HBsAg-
positive humans. Whether this antibody was present in
the form of circulating immune complexes, and whether
it possessed neutralizing activity, was not examined in
this study.
In most ducks an early peak in serum DHBsAg and
DHBV DNA (days 10–14 p.i.) was followed by a marked
decline that coincided with the appearance of anti-DHBc
antibodies (Figs. 1 and 2). The cause of this decline was
not determined but may reflect either decreased levels of
viral release from hepatocytes or increased rates of
removal of virus from the bloodstream. These effects
may be related to the development of specific humoral or
cell-mediated immune responses.
The serological profile of the 7-day-old duck that did
not develop detectable viremia following inoculation with
DHBV (duck 7.1) is shown in Fig. 1B. In this duck and in
all older ducks in this experiment DHBsAg and DHBV
DNA were not detected in the serum, but anti-DHBc
and/or anti-DHBs antibodies were detected in most
ducks (Table 1).
To observe the effect of the dose of virus on the
outcome of infection 7-, 14-, 21-, and 28-day-old ducks
were inoculated i.v. with 1 3 106 DHBV genomes. Inoc-
ulation with this higher dose resulted in persistent vire-
mia in all 7- and 14-day-old ducks and but no detectable
viremia in older ducks (Table 1). The serological profile of
a 14-day-old duck that developed persistent viremia fol-
lowing inoculation with 1 3 106 DHBV genomes is shown
in Fig. 1C. Persistent DHBsAg, DHBV DNA, and anti-
DHBc antibodies were detected from day 14 p.i. (DHBV
DNA data not shown), while anti-DHBs antibodies were
not detected at any stage up to day 56 p.i. In ducks with
persistent viremia autopsy liver tissue collected at day
56 p.i. showed mild mononuclear cell infiltration of portal
tracts but no evidence of lobular hepatitis. In contrast,
autopsy liver tissue collected from ducks that had no
detectable viremia had no evidence of viral infection and
normal liver histology. A schematic diagram of the out-
come of DHBV infection in 1- to 42-day-old ducks with
age and dose is shown in Fig. 3.
In ducks without detectable viremia the anti-DHBc and
anti-DHBs antibody responses were usually low and
transient (i.e., lasting no more than 15–30 days). As liver
biopsies were not performed it could not be confirmed
FIG. 1. The outcome of DHBV infection in newly hatched ducks was
determined by the dose of inoculated virus and the age at the time of
inoculation. Serological profiles of a (A) 1-day-old (1.2) and (B) a 7-day-old duck
(7.1) inoculated i.v. with 4 3 104 DHBV genomes and (C) a 14-day-old duck
inoculated i.v. with 1 3 106 DHBV genomes. Serum samples were collected
twice a week from days 1–56 p.i. DHBsAg and anti-DHBc and anti-DHBs
antibodies were detected by ELISA; DHBV DNA was detected by spot blot
hybridization. Levels of serum DHBV DNA have been expressed in pg/ml (1 3
104 pg/ml is equivalent to 3.3 3 109 DHBV genomes/ml).
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whether limited viral replication had occurred early after
infection or whether the weak immune response de-
tected was induced by the initial inoculum. However, it is
likely that viral replication had occurred as 14-day-old
ducks inoculated with 1 3 107 DHBV genomes had
detectable viral replication in ;0.001% of hepatocytes on
day 4 p.i. (Triyatni et al., unpublished), indicating that
ducks of this age are susceptible to viral infection. It was
concluded that the switch in outcome from persistent
viremia to no detectable viremia occurred at a sharply
defined age in newly hatched ducks. A 25-fold increase
in the dose of virus could delay by 7 days the age at
which host defenses could overcome and suppress in-
fection and further increases in dose of virus may have
resulted in longer delays. This suggested that the bal-
ance of factors determining the extent of viral replication
and host immune response was relatively consistent
from duck to duck and that once each individual duck
became committed to one of the two possible outcomes
this was sustained.
Effect of inoculum dose on the outcome of DHBV
infection in 4-month-old ducks
In HBV infection, a lower dose of inoculum increases
the proportion of asymptomatic infections and extends
the incubation period (Barker and Murray, 1972). To ex-
amine this in DHBV infection, serological responses to
infection were monitored following i.v. inoculation of
4-month-old ducks with pooled serum containing 1 3
103, 1 3 106, 1 3 109, and 2 3 1011 DHBV genomes.
Following inoculation weekly serum samples were mon-
itored for DHBsAg and anti-DHBc and anti-DHBs anti-
bodies by ELISA and for DHBV DNA by spot blot hybrid-
ization.
Ducks that received 1 3 103, 1 3 106, or 1 3 109 DHBV
genomes had no detectable viremia, and all developed
anti-DHBc (Fig. 4A) and anti-DHBs (Fig. 4B) antibodies
with higher titers and shorter time to appearance of
detectable antibody when larger doses of virus were
used. Antibody production is likely to have resulted from
low-level transient infection, at least with the smaller
doses of virus where the amount of inoculated antigen
(estimated to be 5 pg of DHBsAg and 0.01 pg of DHBcAg
for pooled serum containing 1 3 103 DHBV genomes)
would be unlikely to elicit a detectable immune response
per se. For comparison, vaccination of 21-day-old ducks
with 20 mg of yeast-derived DHBV surface antigen pro-
duced a very weak antibody response (an OD of 0.1 at a
serum dilution of 1/25) on day 14 postvaccination (M.
Triyatni et al., unpublished).
Liver biopsy tissue collected on days 6, 9, or 12 p.i.
FIG. 2. Spot blot hybridization of DHBV DNA in serum samples
collected on days 1–56 p.i. from 1 (1.1, 1.2)-, 7 (7.1, 7.2)-, and 14 (14.1,
14.2)-day-old ducks that received 4 3 104 DHBV genomes or an equal
volume of NDS. Dilutions of the pooled serum inoculum are shown as
the positive control (POS). Duplicate spot blot assays were performed
on each serum sample.
FIG. 3. Diagrammatic representation of age-related outcomes of DHBV infection in 1- to 42-day-old ducks inoculated i.v. with 4 3 104 or 1 3 106
DHBV DNA genomes.
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from the 4-month-old ducks receiving 1 3 103, 1 3 106, or
1 3 109 DHBV genomes showed insignificant or minimal
infiltration of mononuclear cells in portal tracts (Fig. 5A)
and no evidence of viral antigen expression or replica-
tion by immunoperoxidase staining (Fig. 5D) or Southern
blot hybridization (data not shown). In contrast, 3-day-old
ducks inoculated i.v. with a similar dose of DHBV (1500
ID50; Jilbert et al., 1996) showed exponential increases in
the percentage of infected hepatocytes with a mean
doubling time of 16 h resulting in DHBV replication in
.95% of hepatocytes by day 14 p.i. Thus, results from the
current study suggested either that the rate of viral rep-
lication was slower in older ducks or that host responses
to DHBV infection had prevented cell-to-cell spread of
the virus. Differences in the rate of viral replication in the
liver of ducks of different ages were not assessed in the
current study. A failure to detect very limited viral repli-
cation in liver biopsy tissue might occur due to problems
with timing or sensitivity of the assays for viral replication
in the liver. We estimated that the maximum percentage
of liver cells receiving viral particles at doses of 1 3 103,
1 3 106, or 1 3 109 DHBV genomes were 0.0000016,
0.0016, and 1.6%, respectively. These estimates were
based on 4-month-old ducks with an average body
weight of 2.5 kg. The liver contributes 3.1–4.1% to this
weight (Nickel et al., 1977) and contains 7 3 108 cells/
gram (Jilbert et al., 1992), resulting in a total of ;5.4–7.1 3
1010 liver cells per duck.
Ducks receiving 2 3 1011 DHBV genomes developed
anti-DHBc antibodies and transient viremia between
days 7 and 21 p.i. (Fig. 6). Liver biopsy tissue collected on
days 9 and 12 p.i. (ducks W24 and W25, respectively)
showed viral replication in .95% of hepatocytes (Figs.
5E and 5F) that could have resulted from infection of all
hepatocytes by the original inoculum. Using calculations
similar to the above we estimated that each cell in the
liver of these ducks might have received a maximum of
2.8–3.7 DHBV genomes per liver cell.
Extensive mononuclear cell infiltration in portal tracts
and lobular hepatitis was seen in the livers of all three
ducks inoculated with 2 3 1011 DHBV genomes (Figs. 5B
and 5C; W23 data not shown). Anti-DHBs antibodies
were detected in only one of three ducks (W24) from day
14 p.i. However, by day 120 p.i. ducks W24 and W25 no
longer had detectable viral replication or histological
changes in the liver, while duck W23 still showed per-
sistent viral replication in .95% of hepatocytes and mod-
erate histological changes including mononuclear cell
infiltration and lobular hepatitis. Studies are in progress
to characterize the infiltrating mononuclear cell popula-
tions in the liver using assays developed in our labora-
tory (Bertram et al., 1996, 1997a,b; Bertram, 1997).
In summary, increasing the dose of inoculated virus
shortened the time to appearance and the levels of
detectable antibodies, and an increase in the inocu-
lum from 1 3 109 to 2 3 1011 DHBV genomes resulted
in the appearance of transient viremia and extensive
infection of the liver, with histological evidence of
moderately severe acute hepatitis on days 9–12 p.i.
Two of the three 4-month-old ducks receiving the high-
est dose of virus were able to resolve their DHBV
infection despite the development of extensive viral
replication in the liver and detectable viremia early
after infection. Thus, in contrast to newly hatched
ducks, two of three 4-month-old ducks inoculated with
2 3 1011 DHBV genomes, and all 4-month-old ducks
FIG. 4. Serological responses to DHBV infection in four groups of
three 4-month-old ducks inoculated i.v. with 1 3 103, 1 3 106, 1 3 109,
or 2 3 1011 DHBV genomes. Serum samples were collected weekly
from days 7–42 p.i. Levels of anti-DHBc (A) and anti-DHBs (B) antibod-
ies were detected by ELISA and have been presented as the average
titer of the group of three ducks inoculated with each dose. All ducks
inoculated with DHBV developed anti-DHBc and anti-DHBs antibodies
which were detected in the serum at higher dilutions than NDS. The
reciprocal dilution of NDS that produced an OD of 0.4 (‘‘negative mean’’)
in each assay has been shown as a dashed line (• • • • ).
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inoculated with lower doses of virus, were able to
resolve their DHBV infection.
Detailed outcomes following inoculation of high doses
of virus to older ducks
We wished to examine in more detail the outcome of
inoculation of older ducks with high doses of virus. Five
10- to 16-month-old ducks were inoculated with 2 3 1011
DHBV genomes and monitored by taking regular blood
samples and paired liver biopsies on days 4–6 and
35–47 p.i. in different ducks.
In four of five ducks, viremia was not detected and
anti-DHBc and anti-DHBs antibodies were detected from
day 8 p.i. onward (Fig. 7A). DHBV replication was shown
by the presence of DHBsAg in 18–56% of hepatocytes in
the first liver biopsy (days 4–6 p.i.), but by days 35–47 p.i.
no evidence for viral replication was found either by
immunohistochemistry or by Southern blot hybridization.
Histopathological changes including mild lobular hepa-
titis, interface hepatitis (piecemeal necrosis), and a mild
to moderate infiltrate of mononuclear cells in portal
tracts were present in three of the ducks in this group in
the acute phase (days 4–6), but not in the preinfection or
in the second (days 35–47) liver biopsy specimen.
In contrast to the above transient (‘‘typical’’) re-
sponse, the fifth duck (duck B30R78) had prolonged
infection; 39.6 and .95% of hepatocytes were positive
for DHBsAg on days 4 and 46 p.i. Viral DNA persisted
to high levels in the liver on day 46 p.i. and covalently
closed circular DNA (cccDNA) was still detectable at
0.03 DHBV genomes per liver cell on days 162 and
413 p.i. (Fig. 7B). No other viral replicative intermedi-
ates were detected on days 162 and 413 p.i. Viremia
persisted for .30 days but had disappeared by day
413 p.i.; sustained anti-DHBc antibodies developed but
no anti-DHBs antibodies were detected (Fig. 7B). This
duck developed moderately severe chronic hepatitis
with interface hepatitis that was still significant on day
162 p.i. but had resolved by day 413 p.i.
DISCUSSION
The outcomes of DHBV infection demonstrated above
(persistent viremia or transient infection with and without
viremia and liver damage of varying duration and inten-
sity) are analogous to some of the different outcomes
that follow HBV infection in humans (Lok, 1992). Charac-
terization of the mechanisms that determine these out-
comes should provide a framework for considering sim-
ilar issues with HBV. In both cases, the age at the time of
infection has a pronounced effect and under the condi-
tions defined above the host and viral factors involved
appear to be finely balanced.
Viral infections of humans provide numerous exam-
ples where the age of the host at the time of infection
alters the severity of symptoms. For example, rotavi-
ruses and respiratory syncytial virus cause more se-
FIG. 5. Liver biopsy tissue collected from duck W7 (inoculated with 1 3 103 DHBV genomes) on day 12 p.i. (A, D), duck W24 (inoculated with 2 3
1011 DHBV genomes) on day 9 p.i. (B, E), and duck W25 (inoculated with 2 3 1011 DHBV genomes) on day 12 p.i. (C, F). Histological changes included
moderate to marked mononuclear cell infiltrates in liver biopsy tissue from ducks W24 (B) and W25 (C) but not duck W7 (A). Sections stained with
H&E. DHBV replication was detected by immunoperoxidase staining of DHBsAg in the cytoplasm of .95% of hepatocytes in ducks W24 (E) and W25
(F) but not duck W7 (D). Sections counterstained with hematoxylin. Original magnification A–C 370 (bar, 100 mm). Original magnification D–F 3140
(bar, 50 mm).
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vere infections in infants and very young children,
while varicella, mumps, poliovirus, and EBV cause
milder infections in children than in adults. A number
of viral infections of animals also exhibit age-related
effects on severity of infection and viral persistence.
Examples where virulence is increased in younger
mice include mouse hepatitis virus (Barthold et al.,
1993), K virus (Greenlee, 1981), Sindbis virus (Griffin et
al., 1994), human herpes simplex virus type 1 (Kintner
and Brandt, 1995), rotavirus (Ramig, 1988), and Thei-
ler’s virus (Steiner et al., 1984). Reovirus infection is
also more severe in newly hatched than in older chick-
ens (Montgomery et al., 1986; Roessler and Rosen-
berger, 1989), while poliovirus infection in mice is less
likely to produce paralysis in the very young (Jubelt et
al., 1980). In many of the above examples, viral repli-
cation itself causes cell damage, and proposed mod-
els for the effect of age include both increasing mat-
uration of the immune system with age and a link
between host cell maturation and the capacity to sup-
port viral replication.
The effect of the dose of virus on the immune re-
sponse to infection has also been recently studied in
neonatal mice inoculated with murine leukemia virus
(Sarzotti et al., 1996). Low doses of virus were able to
induce a protective cytotoxic T lymphocyte (CTL) re-
sponse, whereas high doses of virus failed to induce a
CTL response but led to a nonprotective type 2 cytokine
response. This work suggests that the initial viral dose
may be critical in determining whether newborn animals
develop protective or nonprotective immunity.
Other recent studies in neonatal mice have shown that
classical protocols for inducing tolerance to protein an-
tigens produce a vigorous type 2 cytokine response
(Barrios et al., 1996; Forsthuber et al., 1996). Further
studies have shown that the mode of antigen presenta-
tion and the dose may determine whether tolerance or
immune responsiveness is the final outcome (Ridge et
al., 1996). Our results raise the possibility of similar
mechanisms in the interaction between DHBV and the
newly hatched host.
Noncytopathic viruses such as DHBV and HBV may
induce immune responses that result in elimination of
virus and/or damage to infected host cells. The balance
between viral spread and the kinetics of the develop-
ment of an immune response may determine whether
immune elimination of virus or immunopathology will
predominate. In the model proposed by Zinkernagel
(1996), three alternative scenarios are described: (i) per-
sistent infection with only minimal initial disease, (ii)
more prolonged infection with more extensive disease,
or (iii) transient infection with minimal disease, depend-
ing on the overall equilibrium between levels of viral
replication and immune response. The results of the
current study are consistent with the alternatives defined
by Zinkernagel (1996). In recently hatched ducks, the
usual outcomes were persistent viremia with minimal
disease or transient antibody production. The study dem-
onstrates that the ability of ducks to mount immune
responses to resolve DHBV infection is linked to the age
of the duck. This may reflect the relative maturity of the
immune system affecting the capacity to respond to
FIG. 6. Serological markers of DHBV infection in three 4-month-old
ducks inoculated i.v. with 2 3 1011 DHBV genomes. (A) Duck W23; (B)
duck W24; (C) duck W25. Serum samples were collected weekly from
days 7–42 p.i. DHBsAg and anti-DHBc and anti-DHBs antibodies were
detected by ELISA; DHBV DNA was detected by spot blot hybridization.
The reciprocal dilution of NDS that produced an OD of 0.4 (‘‘negative
mean’’) in the anti-DHBS antibody assay has been shown as a dashed
line (• • • • ).
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antigen and/or to the number of cells present that are
able to respond.
In older ducks, transient infection with more extensive
disease with or without viremia was the more typical
response. In contrast to recently hatched ducks, these
older ducks were able to mount effective immune re-
sponses despite inoculation of up to 7 logs more virus
and the development of extensive infection of the liver
leading to detectable viremia. Two ducks showed pro-
longed viremia with continuing disease in a manner that
may be analogous to chronic active hepatitis reported in
HBV infection.
Furthermore, in the example of Hepadnaviruses, we
have previously reported rapid resolution of infection with-
out significant cell death and regeneration in transient
DHBV and WHV infections (Jilbert et al., 1992; Kajino et al.,
1994). Guidotti et al. (1996) have also proposed that local
cytokine production may be responsible for viral elimination
without hepatocyte injury. Thus, in the equilibria proposed
above, cytotoxic T-cell-mediated hepatocyte injury (if it oc-
curs) and cytokine-mediated viral elimination may involve
different and separable mechanisms.
In summary, we have identified different conditions of
host age and dose of inoculum that lead to the different
FIG. 7. Typical (A) and atypical (B) outcomes of DHBV infection in adult ducks B39R85 and B30R78 (10 and 11 months old at the time of initial
inoculation, respectively). Each duck was inoculated i.v. with pooled serum containing 2 3 1011 DHBV genomes. The time course of DHBV infection
was studied by analysis of liver biopsy tissues for viral replication, viral antigen expression, and liver pathology and by analysis of serum samples
for DHBV DNA, DHBsAg, anti-DHBc, and anti-DHBs antibodies. Viral cccDNA (0.03 DHBV genomes per liver cell), but no other viral replicative
intermediates, were detected in liver tissue on days 162 and 413 p.i. (6).
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outcomes of infection proposed in a model for a noncy-
topathic virus where viral parameters and development
of an effective immune response are in competition.
Further studies to define the various immunological and
virological components of this equilibrium with DHBV
should provide further insights into HBV pathogenesis.
MATERIALS AND METHODS
Animals
DHBV-negative Pekin–Aylesbury cross-bred ducks
and congenitally DHBV-infected Pekin ducks (Anas do-
mesticus platyrhynchos) were obtained on the day of
hatching from two independent commercial suppliers
and were housed in separate animal holding facilities.
Animal handling protocols were reviewed and approved
by the Institute of Medical and Veterinary Science (IMVS)
and University of Adelaide Animal Ethics Committees
and followed the Australian National Health and Medical
Research Committee guidelines.
Pooled serum inoculum
An infectious serum pool was prepared from blood
obtained by cardiac puncture of 21-day-old congenitally
DHBV-infected ducks as previously described (Jilbert et
al., 1996). The pooled serum contained 9.5 3 109 DHBV
genomes/ml and 50 mg/ml DHBsAg (Jilbert et al., 1996).
The infectivity titer of the pooled serum inoculum was
previously determined in 3-day-old ducks to be 1.5 3
1010/ml, with a 95% confidence interval of 3.0 3 109–
6.3 3 1010 ID50/ml (Jilbert et al., 1996). All dilutions of this
serum were performed in normal duck serum (NDS)
prepared from DHBV-negative ducks.
Infection experiments
(1) Groups of ducks (4 or 2 ducks per group) were
inoculated i.v. via the jugular vein at 1, 7, 14, 21, 28, 35, and
42 days of age with pooled serum containing 4 3 104
DHBV genomes or at 7, 14, 21, and 28 days of age with
1 3 106 DHBV genomes. One control duck from each age
group was inoculated with an equal volume of NDS. (2)
Groups of 4-month-old ducks (3 ducks per group) were
inoculated i.v. with NDS or with pooled serum containing
1 3 103, 1 3 106, 1 3 109, and 2 3 1011 DHBV genomes.
Ducks receiving 2 3 1011 DHBV genomes (20 ml of
pooled serum inoculum) were inoculated via an i.v. 18-
gauge 3.2-cm catheter/needle unit (Insyte, Becton–Dick-
inson) with a 25-cm extension tube (Tuta Laboratories,
Australia). (3) A group of 5, 10- to 16-month-old ducks
were similarly inoculated i.v. with 2 3 1011 DHBV ge-
nomes.
Serological assays
The DHBV DNA content of serum samples was deter-
mined either directly by spot blot hybridisation or after
pelleting (through 20% sucrose) and pronase SDS diges-
tion by Southern blot hybridization. Genomic-length
DHBV DNA excised from plasmid pSP.DHBVS.2Galx2
was used as an internal standard in all blots (Pugh et al.,
1988). Genome copy number was calculated from the
relationship that one DHBV genome contains 3 3 1026
pg DNA. DHBsAg levels in serum were quantitated by
ELISA using a standard curve constructed using dilu-
tions of the DHBV-positive pooled serum (Jilbert et al.,
1996). Antibodies to DHBsAg (anti-DHBs) were detected
in an indirect ELISA by addition of diluted serum to
96-well microtiter plates after sequential coating with a
1/10,000 dilution of monoclonal anti-preS antibody (1H.1;
Pugh et al., 1995) and DHBsAg particles purified on a
20–50% sucrose gradient. Anti-DHBs antibodies bound
specifically to the DHBsAg were then detected with rab-
bit anti-duck Ig (prepared using duck egg yolk Ig; Ber-
tram, 1997) and goat anti-rabbit HRP (Silenus). Since this
assay used DHBsAg particles, it would detect both anti-S
and anti-preS antibodies. Antibodies to DHBV core anti-
gen (anti-DHBc) were similarly detected by addition of
diluted serum to microtiter plates coated with recombi-
nant DHBcAg produced in E. coli (Jilbert et al., 1992).
Bound antibody was detected with rabbit anti-duck Ig
and goat anti-rabbit HRP. In all assays HRP was visual-
ized using OPD substrate measured at an OD of 490 nm.
Titers of antiviral antibodies were expressed either as
the reciprocal log of the serum dilution that produced an
OD value of 0.2–0.5 in different assays or as the OD
produced at a standard dilution of serum. In general the
levels of anti-DHBc antibodies detected were 1–2 logs
higher than those of anti-DHBs antibodies. However,
differences in assay design make it difficult to make
absolute comparisons.
DHBV antigen and DNA detection in tissues
Open wedge biopsies of liver were performed as pre-
viously described (Carp et al., 1991) following anestheti-
zation with isofluorane:O2:N2O (4%:1.5 L/min:400 ml/min)
and intubation with an endotracheal tube (size 2.5 oral;
Mallinckrodt Medical, Ireland). Samples (3–4 mm3) of
liver biopsy tissue were fixed in ethanol:acetic acid (EAA)
or 10% neutral buffered Formalin prior to processing and
wax embedding. DHBsAg and DHBcAg were detected in
EAA-fixed tissues by standard immunoperoxidase tech-
niques using rabbit anti-recombinant DHBcAg serum (Jil-
bert et al., 1992) or mouse monoclonal anti-preS antibod-
ies (1H.1) followed by HRP-conjugated sheep anti-mouse
Ig and diaminobenzidine. Histological analysis was per-
formed using coded sections of Formalin-fixed liver tis-
sue stained by H&E. Total and non-protein-bound DNA
was also purified from snap frozen liver tissue and ana-
lyzed for DHBV DNA by Southern blot hybridization, ex-
actly as previously described (Jilbert et al., 1992).
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